137 related articles for article (PubMed ID: 25550154)
1. A novel collagen-nanohydroxyapatite microRNA-activated scaffold for tissue engineering applications capable of efficient delivery of both miR-mimics and antagomiRs to human mesenchymal stem cells.
Mencía Castaño I; Curtin CM; Shaw G; Murphy JM; Duffy GP; O'Brien FJ
J Control Release; 2015 Feb; 200():42-51. PubMed ID: 25550154
[TBL] [Abstract][Full Text] [Related]
2. Next generation bone tissue engineering: non-viral miR-133a inhibition using collagen-nanohydroxyapatite scaffolds rapidly enhances osteogenesis.
Mencía Castaño I; Curtin CM; Duffy GP; O'Brien FJ
Sci Rep; 2016 Jun; 6():27941. PubMed ID: 27297802
[TBL] [Abstract][Full Text] [Related]
3. Harnessing an Inhibitory Role of miR-16 in Osteogenesis by Human Mesenchymal Stem Cells for Advanced Scaffold-Based Bone Tissue Engineering.
Mencía Castaño I; Curtin CM; Duffy GP; O'Brien FJ
Tissue Eng Part A; 2019 Jan; 25(1-2):24-33. PubMed ID: 29490603
[TBL] [Abstract][Full Text] [Related]
4. Rapid bone repair with the recruitment of CD206
Castaño IM; Raftery RM; Chen G; Cavanagh B; Quinn B; Duffy GP; O'Brien FJ; Curtin CM
Acta Biomater; 2020 Jun; 109():267-279. PubMed ID: 32251781
[TBL] [Abstract][Full Text] [Related]
5. Development of a gene-activated scaffold platform for tissue engineering applications using chitosan-pDNA nanoparticles on collagen-based scaffolds.
Raftery RM; Tierney EG; Curtin CM; Cryan SA; O'Brien FJ
J Control Release; 2015 Jul; 210():84-94. PubMed ID: 25982680
[TBL] [Abstract][Full Text] [Related]
6. An efficient, non-viral dendritic vector for gene delivery in tissue engineering.
Walsh DP; Heise A; O'Brien FJ; Cryan SA
Gene Ther; 2017 Nov; 24(11):681-691. PubMed ID: 28905887
[TBL] [Abstract][Full Text] [Related]
7. The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds.
Tierney EG; Duffy GP; Hibbitts AJ; Cryan SA; O'Brien FJ
J Control Release; 2012 Mar; 158(2):304-11. PubMed ID: 22138069
[TBL] [Abstract][Full Text] [Related]
8. Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing.
Castaño IM; Raftery RM; Chen G; Cavanagh B; Quinn B; Duffy GP; Curtin CM; O'Brien FJ
Acta Biomater; 2023 Dec; 172():480-493. PubMed ID: 37797708
[TBL] [Abstract][Full Text] [Related]
9. Development of a Gene-Activated Scaffold Incorporating Multifunctional Cell-Penetrating Peptides for pSDF-1α Delivery for Enhanced Angiogenesis in Tissue Engineering Applications.
Power RN; Cavanagh BL; Dixon JE; Curtin CM; O'Brien FJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163379
[TBL] [Abstract][Full Text] [Related]
10. Development of miR-26a-activated scaffold to promote healing of critical-sized bone defects through angiogenic and osteogenic mechanisms.
Sadowska JM; Ziminska M; Ferreira C; Matheson A; Balouch A; Bogle J; Wojda S; Redmond J; Elkashif A; Dunne N; McCarthy HO; Donahue S; O'Brien FJ
Biomaterials; 2023 Dec; 303():122398. PubMed ID: 37979514
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression.
Lee HK; Finniss S; Cazacu S; Xiang C; Brodie C
Stem Cells Dev; 2014 Dec; 23(23):2851-61. PubMed ID: 25036385
[TBL] [Abstract][Full Text] [Related]
12. Macrochanneled bioactive ceramic scaffolds in combination with collagen hydrogel: a new tool for bone tissue engineering.
Yu HS; Jin GZ; Won JE; Wall I; Kim HW
J Biomed Mater Res A; 2012 Sep; 100(9):2431-40. PubMed ID: 22566478
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold.
Curtin CM; Tierney EG; McSorley K; Cryan SA; Duffy GP; O'Brien FJ
Adv Healthc Mater; 2015 Jan; 4(2):223-7. PubMed ID: 25125073
[TBL] [Abstract][Full Text] [Related]
14. Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds.
Sun XD; Jeng L; Bolliet C; Olsen BR; Spector M
Biomaterials; 2009 Feb; 30(6):1222-31. PubMed ID: 19059640
[TBL] [Abstract][Full Text] [Related]
15. Layered Double Hydroxide as a Potent Non-viral Vector for Nucleic Acid Delivery Using Gene-Activated Scaffolds for Tissue Regeneration Applications.
Costard LS; Kelly DC; Power RN; Hobbs C; Jaskaniec S; Nicolosi V; Cavanagh BL; Curtin CM; O'Brien FJ
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33339452
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering.
Liu Y; Teoh SH; Chong MS; Yeow CH; Kamm RD; Choolani M; Chan JK
Tissue Eng Part A; 2013 Apr; 19(7-8):893-904. PubMed ID: 23102089
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro and in vivo osteogenic differentiation of nano-hydroxyapatite/chitosan/poly(lactide-co-glycolide) scaffolds with human umbilical cord mesenchymal stem cells.
Wang F; Zhang YC; Zhou H; Guo YC; Su XX
J Biomed Mater Res A; 2014 Mar; 102(3):760-8. PubMed ID: 23564567
[TBL] [Abstract][Full Text] [Related]
18. Electrospun polyurethane/hydroxyapatite bioactive scaffolds for bone tissue engineering: the role of solvent and hydroxyapatite particles.
Tetteh G; Khan AS; Delaine-Smith RM; Reilly GC; Rehman IU
J Mech Behav Biomed Mater; 2014 Nov; 39():95-110. PubMed ID: 25117379
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic differentiation of mesenchymal stem cells in fibrin-hydroxyapatite matrix in a 3-dimensional mesh scaffold.
Jung O; Hanken H; Smeets R; Hartjen P; Friedrich RE; Schwab B; Gröbe A; Heiland M; Al-Dam A; Eichhorn W; Sehner S; Kolk A; Wöltje M; Stein JM
In Vivo; 2014; 28(4):477-82. PubMed ID: 24982212
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical mesoporous bioactive glass/alginate composite scaffolds fabricated by three-dimensional plotting for bone tissue engineering.
Luo Y; Wu C; Lode A; Gelinsky M
Biofabrication; 2013 Mar; 5(1):015005. PubMed ID: 23228963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
